XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Unaudited Condensed Consolidated Statements Of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Revenue:    
Total revenue $ 1,270,255 $ 970,321
Cost of revenue:    
Amortization of intangible assets 13,360 11,886
Total cost of revenue 256,984 207,999
Gross margin 1,013,271 762,322
Operating expenses:    
Research and development 383,971 357,468
Sales and marketing 180,510 170,628
General and administrative 81,008 77,488
Amortization of intangible assets 9,000 8,390
Restructuring charges 11,746 0
Total operating expenses 666,235 613,974
Operating income 347,036 148,348
Other income (expense), net (19,793) 28,756
Income before income taxes 327,243 177,104
Provision for income taxes 13,902 15,076
Net income 313,341 162,028
Net income (loss) attributed to non-controlling interest (346) (317)
Net income attributed to Synopsys $ 313,687 $ 162,345
Net income per share attributed to Synopsys:    
Basic (in USD per share) $ 2.05 $ 1.06
Diluted (in USD per share) $ 1.99 $ 1.03
Shares used in computing per share amounts:    
Basic (shares) 153,218 152,498
Diluted (shares) 157,273 157,277
Time-based products    
Revenue:    
Total revenue $ 707,483 $ 631,290
Cost of revenue:    
Cost of revenue 165,399 127,347
Upfront products    
Revenue:    
Total revenue 368,274 174,381
Maintenance and service    
Revenue:    
Total revenue 194,498 164,650
Cost of revenue:    
Cost of revenue $ 78,225 $ 68,766